La cadena de opciones muestra datos clave de las opciones de acciones de Mercedes-Benz Group a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Mercedes-Benz Group..

Mercedes-Benz Group (OTC:MBGYY) Bolsa, Cadena de Opciones

Mercedes-Benz Group is a premium automotive original equipment manufacturer, selling around 2 million passenger cars, including its Chinese joint venture, and just under 450,000 vans per year. The company's financial profile improved significantly following the spinoff of Daimler Truck in 2021. Unlike most automotive OEMs, Mercedes operates under its own brand alone. In 2023, 16% of its passenger cars sold were top end (G Class, Maybach, AMG, S Class), 54% were core (C and E Class), and 30% entry (A and B Class). In volume terms, Asia is Mercedes' largest market at 40% of 2023 vehicle sales followed by Europe at 38% and North America at 17%.

News

MBGYY

Mercedes-Benz planea abrir 20 nuevas sucursales en India para 2025, enfocándose en ciudades más pequeñas impulsadas por jóvenes emprendedores.

Mercedes-Benz ampliará su red en India con 20 nuevas sucursales para 2025

BMWYY

CRZBF

CTTAY

IDEXY

RNLSY

UNCRY

VWAGY

El Ibex 35 cae y el sector automovilístico sufre fuertes pérdidas. Inditex reporta ganancias mientras el mercado espera el IPC de EE.UU.

¿Cómo se moverá el Ibex 35 hoy? Expectativas tras las caídas del martes

AAPL

Porsche Automobile Holding SE Unsponsored

POAHY

RACE

STLA

Descubre por qué las acciones de las principales compañías automotrices están cayendo y cómo el coche eléctrico está alterando el mercado.

El motor europeo se toma una pausa en bolsa

Mercedes-Benz Group AG

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) from Buy to Buy.

Reiteration

Analyst Ratings

CYTK

HC Wainwright & Co. Reiterates Buy on Cytokineticsto Buy

YMAB

Y-mAbs Internally Realigns Operations With Establishment Of Two Business Units: Radiopharmaceuticals And DANYELZA; Plans Reduction In Its Current Workforce Of Up To 13%

Piper Sandler analyst Anna Andreeva upgrades Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) from Neutral to Overweight and raises the price target from $72 to $90.

Upgrades

Price Target

Piper Sandler Upgrades Nike to Overweight, Raises Price Target to $90

<ul>
<li>Primary endpoint met in phase 2a POC trial in postpartum depression with a MADRS reduction from baseline of –35.4 points&nbsp;(p&lt;0.0001, n=10) and 100% of patients in remission at Day 8</li>
<li>Primary endpoint met in phase 2a POC trial in bipolar II disorder with a current major depressive episode with a MADRS reduction from baseline of –16.8 points&nbsp;(p=0.0099, n=6) and 33% of patients in remission at Day 8</li>
<li>In both trials, GH001 was well tolerated and no treatment-related serious adverse events were reported</li>
<li>Inhalation toxicology study in a non-rodent species was completed with no histology findings in the respiratory tract of any dogs in the study at any dose level</li>
<li>Additional inhalation toxicology study in rats was completed supporting our position that respiratory tract histology findings are rat specific</li>
<li>Our response to FDA's request for additional device design verification information is being prepared</li>
<li>Full response to the IND hold planned to be submitted in mid-2025</li>
<li>Top-line data from our randomized, double-blind, placebo-controlled Phase 2b trial in TRD on track to be announced in Q1 2025</li>
</ul>

Biotech

Health Care

General

GHRS

GH Research Said It Met Primary Endpoint In Phase 2a Proof-Of-Concept Trial In Postpartum Depression And Phase 2a Proof-Of-Concept Trial In Bipolar II Disorder With Current Major Depressive Episode

UBS analyst Jay Sole upgrades Gildan Activewear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIL#NYSE">GIL</a>) from Neutral to Buy and raises the price target from $50 to $60.

UBS Upgrades Gildan Activewear to Buy, Raises Price Target to $60

MATW

Matthews International Announced That It Has Filed Definitive Proxy Materials With The Securities And Exchange Commission In Connection With Its Upcoming Annual Meeting Of Shareholders Scheduled To Be Held On February 20

Asset Sales

NovaBay Pharmaceuticals Sells Wound Care Trademarks NeutroPhase, PhaseOne, And OmniPhase To Phase One Health For $500K

"We are pleased to announce that we reached our target enrollment for our 396-patient Phase 2b trial of rezpegaldesleukin," said Howard W. Robin, President and CEO of Nektar Therapeutics.&nbsp;
"We look forward to announcing the topline data from the 16-week induction treatment period in this study in the second quarter of 2025."
&nbsp;

NKTR

Nektar Therapeutics Completes Target Enrollment In REZOLVE-AD Phase 2B Study Of Rezpegaldesleukin In Patients With Atopic Dermatitis

<ul>
<li>Company establishes two business units with goal of accelerating the advancement of its Radiopharmaceuticals Platform and optimizing the commercial potential of DANYELZA</li>
<li>Preliminary Part A data from GD2-SADA Phase 1 trial demonstrates tolerability and validity of SADA PRIT platform pre-targeting approach; Company expects to present Part A data in the second quarter of 2025</li>
<li>Company reports preliminary estimated unaudited Total Net Revenue of approximately $88 million for the year ended December 31, 2024, within Full Year 2024 top line guidance range</li>
<li>Company reports preliminary estimated unaudited cash, cash equivalents and marketable securities of approximately $67 million as of December 31, 2024, anticipated to support operations into 2027</li>
</ul>

Y-Mabs Therapeutics Said It Is Internally Realigning Operations With The Establishment Of Two Business Units: Radiopharmaceuticals And Danyelza And Announced 2025 Priorities

GENC

Gencor Announces Receipt Of nyse Regulation Notice Regarding Late Filing Of The Annual Report On Form 10-k For The Year Ended September 30, 2024

The settlement agreement&nbsp;permits&nbsp;Sandoz&nbsp;to begin selling generic versions of CAPLYTA on July 1, 2040, or earlier under certain circumstances.
Similar patent litigation brought by Intra-Cellular Therapies against other parties remains pending in the U.S. District Court for the District of New Jersey.&nbsp;

Legal

ITCI

Intra-Cellular Therapies Enters Settlement Agreement With Sandoz Resolving Patent Litigation Related To CAPLYTA Patent; No Terms Disclosed

ProMIS Neurosciences Says It Initiates Phase 1B Clinical Trial (PRECISE-AD) In Alzheimer's Disease

Mizuho analyst John Baumgartner maintains Simply Good Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMPL#NASDAQ">SMPL</a>) with a Outperform and lowers the price target from $48 to $45.

SMPL

Mizuho Maintains Outperform on Simply Good Foods, Lowers Price Target to $45

<ul>
<li>Chris Smith to retire effective April 1, 2025; Board Member Tony Zook named incoming CEO</li>
<li>Company reaffirms Fiscal 2024 financial guidance</li>
</ul>

Management

Neogenomics Announced That Chris Smith Will Retire As CEO And Board Member Effective April 1, 2025. Tony Zook, An Independent Board Member Since 2023, Will Assume The Role Of CEO At That Time

NEOG

Neogen Corporation Sees Fy25 Revenue Of $905M-$925M Vs. $934.88M Estimate (Prior View: $925M-$955M)

<h3>Gainers</h3>
<ul>
<li>Vision Marine Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>) stock increased by 83.5% to $2.79 during Friday's pre-market session. The market value of their outstanding shares is at $7.9 million. </li>
<li>Cooper-Standard Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPS#NYSE">CPS</a>) shares moved upwards by 12.35% to $15.19. The company's market cap stands at $262.6 million. </li>
<li>TCTM Kids IT Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCTM#NASDAQ">TCTM</a>) shares rose 12.31% to $0.8. The company's market cap stands at $7.8 million. </li>
<li>Netclass Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTCL#NASDAQ">NTCL</a>) stock rose 10.31% to $7.38. The market value of their outstanding shares is at $129.5 million. </li>
<li>Amesite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) stock moved upwards by 10.0% to $2.97. The company's market cap stands at $8.2 million. </li>
<li>Fly-E Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYE#NASDAQ">FLYE</a>) shares rose 9.81% to $0.65. The company's market cap stands at $15.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>European Wax Center (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWCZ#NASDAQ">EWCZ</a>) shares fell 9.1% to $5.83 during Friday's pre-market session. The market value of their outstanding shares is at $260.9 million. </li>
<li>Soho House (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHCO#NYSE">SHCO</a>) shares decreased by 6.81% to $7.12. The company's market cap stands at $1.3 billion. </li>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) shares declined by 6.37% to $10.01. The company's market cap stands at $201.2 million. </li>
<li>Twin Vee PowerCats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEE#NASDAQ">VEEE</a>) shares declined by 6.07% to $0.45. The company's market cap stands at $6.7 million. </li>
<li>Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) stock decreased by 5.8% to $13.5. The company's market cap stands at $48.6 million. </li>
<li>FAT Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAT#NASDAQ">FAT</a>) stock fell 5.48% to $5.01. The company's market cap stands at $85.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AMST

ARKR

EWCZ

FLYE

FTEL

NTCL

SHCO

TCTM

VEEE

VMAR

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>ZyVersa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) shares rose 44.9% to $1.71 during Friday's pre-market session. The market value of their outstanding shares is at $4.2 million. </li>
<li>Akoya Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKYA#NASDAQ">AKYA</a>) shares moved upwards by 36.09% to $3.62. The market value of their outstanding shares is at $179.4 million. </li>
<li>Precision BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) shares rose 31.55% to $5.92. The company's market cap stands at $45.4 million. </li>
<li>Senseonics Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SENS#AMEX">SENS</a>) shares rose 26.6% to $0.54. The market value of their outstanding shares is at $324.3 million. </li>
<li>PAVmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAVM#NASDAQ">PAVM</a>) stock increased by 19.47% to $0.74. The company's market cap stands at $7.9 million. </li>
<li>Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) stock moved upwards by 19.15% to $0.55. The market value of their outstanding shares is at $65.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>IGM Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGMS#NASDAQ">IGMS</a>) stock decreased by 68.7% to $1.94 during Friday's pre-market session. The market value of their outstanding shares is at $115.3 million. </li>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) stock declined by 28.15% to $0.97. The market value of their outstanding shares is at $18.2 million. </li>
<li>SILO Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) shares fell 19.3% to $1.38. The company's market cap stands at $6.1 million. </li>
<li>ModivCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODV#NASDAQ">MODV</a>) stock declined by 16.98% to $10.37. The company's market cap stands at $148.1 million. </li>
<li>Inspire Veterinary (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) stock fell 15.16% to $0.15. The company's market cap stands at $4.8 million. </li>
<li>Solid Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDB#NASDAQ">SLDB</a>) stock declined by 11.92% to $3.55. The company's market cap stands at $141.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKYA

CLDI

DTIL

IGMS

IVVD

MODV

PAVM

SENS

SILO

SLDB

ZVSA

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Bridger Aerospace Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAER#NASDAQ">BAER</a>) shares increased by 50.9% to $4.21 during Friday's pre-market session. The company's market cap stands at $228.1 million. </li>
<li>Microvast Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) shares rose 31.01% to $2.45. The company's market cap stands at $789.2 million. </li>
<li>Zoomcar Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) shares moved upwards by 18.53% to $2.11. The market value of their outstanding shares is at $11.1 million. </li>
<li>Stem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STEM#NYSE">STEM</a>) shares increased by 16.34% to $0.97. The company's market cap stands at $157.8 million. </li>
<li>AerSale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASLE#NASDAQ">ASLE</a>) shares moved upwards by 14.23% to $6.98. The market value of their outstanding shares is at $371.4 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) shares increased by 12.49% to $0.51. The market value of their outstanding shares is at $74.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Mynaric (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares fell 9.7% to $0.58 during Friday's pre-market session. The company's market cap stands at $14.7 million. </li>
<li>ZIM Integrated Shipping (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) stock fell 8.35% to $18.99. The company's market cap stands at $2.2 billion. </li>
<li>Samfine Creation Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFHG#NASDAQ">SFHG</a>) stock declined by 6.48% to $1.3. The company's market cap stands at $28.9 million. </li>
<li>GEE Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/JOB#AMEX">JOB</a>) stock declined by 6.32% to $0.22. The company's market cap stands at $24.3 million. </li>
<li>Erayak Power Solution Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAYA#NASDAQ">RAYA</a>) stock fell 6.26% to $1.2. The market value of their outstanding shares is at $33.6 million. </li>
<li>Mesa Air Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESA#NASDAQ">MESA</a>) shares fell 5.93% to $1.27. The company's market cap stands at $52.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASLE

BAER

MESA

MVST

MYNA

RAYA

SFHG

STEM

ZCAR

12 Industrials Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>MicroCloud Hologram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) shares rose 28.8% to $2.73 during Friday's pre-market session. The market value of their outstanding shares is at $56.0 million. </li>
<li>WISeKey Intl Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKEY#NASDAQ">WKEY</a>) stock rose 21.76% to $8.0. The company's market cap stands at $89.5 million. </li>
<li>Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) stock rose 19.5% to $2.39. The market value of their outstanding shares is at $40.3 million. </li>
<li>CISO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISO#NASDAQ">CISO</a>) shares moved upwards by 19.0% to $1.44. The market value of their outstanding shares is at $17.0 million. </li>
<li>SEALSQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAES#NASDAQ">LAES</a>) stock rose 17.15% to $6.18. The market value of their outstanding shares is at $485.4 million. </li>
<li>Penguin Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENG#NASDAQ">PENG</a>) stock moved upwards by 15.0% to $22.0. The market value of their outstanding shares is at $1.1 billion. As per the news, the Q1 earnings report came out 2 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Soluna Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNHP#NASDAQ">SLNHP</a>) stock decreased by 16.7% to $7.5 during Friday's pre-market session. </li>
<li>Focus Universal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCUV#NASDAQ">FCUV</a>) stock declined by 9.91% to $0.6. The company's market cap stands at $44.3 million. </li>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) shares declined by 9.24% to $0.55. The market value of their outstanding shares is at $11.7 million. </li>
<li>SPI Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPI#NASDAQ">SPI</a>) stock fell 8.79% to $0.57. The company's market cap stands at $18.0 million. </li>
<li>LeddarTech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LDTC#NASDAQ">LDTC</a>) stock fell 8.76% to $1.25. The company's market cap stands at $44.6 million. </li>
<li>NextTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRP#NASDAQ">NTRP</a>) shares declined by 7.61% to $6.93. The company's market cap stands at $10.0 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CISO

FCUV

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

INTZ

LAES

LDTC

NTRP

Penguin Solutions, Inc. - Ordinary Shares

PENG

SLNHP

WKEY

12 Information Technology Stocks Moving In Friday's Pre-Market Session

HC Wainwright &amp; Co. analyst Patrick Trucchio initiates coverage on Bright Minds Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRUG#NASDAQ">DRUG</a>) with a Buy rating and announces Price Target of $85.

Initiation

DRUG

HC Wainwright & Co. Initiates Coverage On Bright Minds Biosciences with Buy Rating, Announces Price Target of $85

EU carbon targets tighten in 2025, as carmakers grapple with sluggish EV demand and Chinese competition.

European Carmakers' Struggles Likely To Continue In 2025, Analysts Forecast

Mercedes-Benz: Why The Company Is Undervalued Here

Mercedes-Benz: Positioned To Conquer European Car Manufacturer Headwinds

European Truck Market: Speed Slows, CO2 Focus Intensifies

Nissan (NSANY) is slashing production levels at a joint venture manufacturing plant in Mexico, operated with Mercedes-Benz (MBGYY), by roughly 50%,...

Nissan's Mexican JV with Mercedes-Benz halves car output, Nikkei reports

In November, new EU car registrations fell by 1.9%, the ACEA reports. France led the way with a sharp 12.7% decline, followed by Italy, down 10.8%,...

EU new car registrations down 1.9% in November

Honda and Nissan share details on merger talks; Mitsubishi may also come aboard

Honda and Nissan share details of merger talks; Mitsubishi may also come aboard

EV Company News For The Month Of December 2024

In a report released today, Jose Asumendi from J.P. Morgan maintained a Buy rating on Mercedes-Benz Group (MBGAF – Research Report), with a price t...

Comments

Mercedes-Benz Group

Mercedes-Benz Group (MBGYY) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL